NVSEF News and Press, Novartis Ag Basel Akt From 06/08/23

2023-06-08 07:39:39 ET Summary We analyzed Novartis pipeline growth versus patent expiration. Positive adjuvant data for Kisqali could accelerate market share shifts. Novartis' equal weight rating is due to high margin sales lost to generics and risks from US healthcare reform...

2023-05-31 05:55:18 ET Summary Gain Therapeutics is a biotechnology company focused on drug development powered by its SEE-Tx™ target identification platform, which identifies and optimizes binding sites on biological targets that have never before been targeted. The compan...

2023-05-25 19:36:30 ET Summary It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS could generate sales of $6.3 billion by 2030. Roche Holding AG reported positive results reported from ...

2023-05-25 18:00:00 ET Summary High dividend yield companies can help you earn an extra income in the form of dividends, which you can then use to cover your expenses. In this article, I will introduce you to 10 companies that I believe are attractive picks for investors since the...

2023-05-24 11:02:18 ET Summary Agios Pharmaceuticals, Inc. has done well after its pivot to rare diseases. The move has also generated a huge amount of cash. Their SCD trial go/no-go decision will be very important. I have been covering Agios Pharmaceuticals, Inc. ...

2023-05-18 18:00:00 ET Summary I consider companies that combine a relatively high Dividend Yield and Dividend Growth Rate to be particularly attractive for dividend income investors. The reason being that these companies can help you to significantly increase your extra income in...

2023-05-16 16:46:23 ET Summary We continue our analytics coverage of AstraZeneca PLC with a "hold" rating for the next 12 months. AstraZeneca's revenue for the first three months of 2023 was $10.88 billion, down 2.9% from the previous quarter and 4.5% from the first quarter of 202...

2023-05-14 06:57:39 ET Summary WisdomTree International Quality Dividend Growth Fund holds global dividend stocks with quality and growth characteristics. It is well-diversified across countries and sectors, but it is quite concentrated in the top holdings. Historical performa...

2023-05-14 03:56:00 ET Summary Industry-leading pharmaceutical firms are adopting artificial intelligence to drive value for the future of their enterprise. Several companies in the VanEck Pharmaceutical ETF are currently integrating AI into their operations. The global pharma...

2023-05-12 09:15:18 ET Allakos ( NASDAQ: ALLK ) rose ~8% pre-market Friday after Jefferies upgraded the immunology-focused biotech to Buy from Hold, citing an attractive risk-reward setup ahead of a Phase 2 readout for its lead candidate lirentelimab. San Carlos, California-...